Kenneth Kongstad

Dr. Kenneth Kongstad

University of Copenhagen, Department of Drug Design and Pharmacology
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
JAJohan Andersen‐Ranberg
Johan Andersen‐Ranberg
Kenneth KongstadKenneth Kongstad
Kenneth Kongstad
MNMorten Thrane Nielsen
Morten Thrane Nielsen
NJNiels Bjerg Jensen
Niels Bjerg Jensen
IPIrini Pateraki
Irini Pateraki
BHBjoern Hamberger
Bjoern Hamberger
Plant‐derived diterpenoids serve as important pharmaceuticals, food additives, and fragrances, yet their low natural abundance and high structural complexity limits their broader industrial utilization. By mimicking the modularity of diterpene biosynthesis in plants, we constructed 51 functional combinations of class I and II diterpene synthases, 41 of which are “new‐to‐nature”. Stereoselective biosynthesis of over 50 diterpene skeletons was demonstrated, including natural variants and novel enantiomeric or diastereomeric counterparts. Scalable biotechnological production for four industrially relevant targets was accomplished in engineered strains of Saccharomyces cerevisiae.




24 May 2017 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
YZYong Zhao
Yong Zhao
MCMartin Xiaoyong Chen
Martin Xiaoyong Chen
Kenneth KongstadKenneth Kongstad
Kenneth Kongstad
AJAnna Katharina Jäger
Anna Katharina Jäger
Dan StaerkDan Staerk
Dan Staerk

12 July 2021 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
HAHamidreza Ardalani
Hamidreza Ardalani
FAFatemeh Hejazi Amiri
Fatemeh Hejazi Amiri
AHAmin Hadipanah
Amin Hadipanah
Kenneth KongstadKenneth Kongstad
Kenneth Kongstad
Background: Medicinal plants are used to treat various disorders, including diabetes, globally in a range of formulations. While attention has mainly been on the aerial plant parts, there are only a few review studies to date that are focused on the natural constituents present in the plant roots with health benefits. Thus, the present study was performed to review in vivo studies investigating the antidiabetic potential of the natural compounds in plant roots.Methods: We sorted relevant data in 2001–2019 from scientific databases and search engines, including Web of Knowledge, PubMed, ScienceDirect, Medline, Reaxys, and Google Scholar. The class of phytochemicals, plant families, major compounds, active constituents, effective dosages, type of extracts, time of experiments, and type of diabetic induction were described.Results: In our literature review, we found 104 plants with determined antidiabetic activity in their root extracts. The biosynthesis pathways and mechanism of actions of the most frequent class of compounds were also proposed. The results of this review indicated that flavonoids, phenolic compounds, alkaloids, and phytosteroids are the most abundant natural compounds in plant roots with antidiabetic activity. Phytochemicals in plant roots possess different mechanisms of action to control diabetes, including inhibition ofα-amylase andα-glucosidase enzymes, oxidative stress reduction, secretion of insulin, improvement of diabetic retinopathy/nephropathy, slow the starch digestion, and contribution against hyperglycemia.Conclusion: This review concludes that plant roots are a promising source of bioactive compounds which can be explored to develop against diabetes and diabetes-related complications.Graphical